AstraZeneca/Alexion Purchase Held Up by CMA Amid Concerns

In December 2020, pharma giant AstraZeneca (AZ) announced its intention to acquire biopharmaceutical company Alexion. The merger would give AZ an increased portfolio in rare disease and immunology. While the US Federal Trade Commission (FTC) has approved the merger, several...

1 week ago
Investment,Biology,News

AstraZeneca/Alexion Purchase Held Up by CMA Amid Concerns

In December 2020, pharma giant AstraZeneca (AZ) announced its intention to acquire biopharmaceutical company Alexion. The merger would give AZ an increased portfolio in rare disease and immunology. While the US Federal Trade Commission (FTC) has approved the merger, several...

1 week ago

The Current Outlook for Investment in Oncology

Oncology alone accounts for one-third of the global clinical pipeline across all therapeutic areas. In 2024, the global oncology therapeutics sales are forecasted to hit $250 billion. As the world’s largest therapeutic area, it is a highly competitive market with...

4 weeks ago
Investment,Biology,News

The Current Outlook for Investment in Oncology

Oncology alone accounts for one-third of the global clinical pipeline across all therapeutic areas. In 2024, the global oncology therapeutics sales are forecasted to hit $250 billion. As the world’s largest therapeutic area, it is a highly competitive market with...

4 weeks ago